“Increasing Adoption of Advanced 3D culture Technologies”
- One major trend in the global 3D cell culture market is the increasing adoption of advanced 3D culture technologies, such as organoids, spheroids, and scaffold-based models, in drug screening and disease modeling
- These systems better replicate human physiological conditions compared to traditional 2D cultures, enhancing the reliability of preclinical studies and reducing dependence on animal models
- For instance, organoid technology is being increasingly utilized in cancer research and personalized medicine, offering insights into patient-specific drug responses and disease progression
- These advancements are revolutionizing drug development pipelines, improving translational research, and fueling demand for innovative 3D cell culture platforms across pharmaceutical and biotechnology sectors
